Plant ID: NPO15454
Plant Latin Name: Vitex rotundifolia
Taxonomy Genus: Vitex
Taxonomy Family: Lamiaceae
NCBI TaxonomyDB:
413484
Plant-of-the-World-Online:
n.a.
Australia; China
FFAR1; FFAR4; | |
RECQL; NOX4; ALOX15; | |
FLT3; | |
CA2; CA1; CA12; CA9; CA14; CA7; CA4; | |
RORC; | |
NR1H4; | |
MMP12; | |
HIF1A; | |
ABCG2; | |
LMNA; FABP3; FABP4; |
Cytochrome P450 Enzymes: | CYP1B1; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Metallo protease | MMP12 | Matrix metalloproteinase 12 | P39900 | CHEMBL4393 |
Nuclear hormone receptor subfamily 1 group F | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 3.205E-14 | 3.489E-10 | CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.974E-12 | 8.595E-09 | CA1, CA12, CA2, CA4, CA7, CA9 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.204E-07 | 1.638E-04 | CA1, CA12, CA2, CA4, CA7, CA9, MMP12, NR1H4, RORC |
BP | GO:0009987; cellular process | GO:0071310; cellular response to organic substance | 3.646E-06 | 2.695E-03 | ALOX15, CYP1B1, FABP4, FFAR4, FLT3, HIF1A, NOX4, NR1H4, RORC |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.712E-06 | 2.695E-03 | CA2, CA7 |
MF | GO:0005488; binding | GO:0005504; fatty acid binding | 3.685E-06 | 2.695E-03 | FABP3, FABP4, FFAR4 |
BP | GO:0065007; biological regulation | GO:0055081; anion homeostasis | 1.329E-05 | 8.039E-03 | CA12, FABP3, NR1H4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 5.489E-18 | 1.195E-13 | CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.299E-17 | 4.935E-16 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 6.290E-05 | 1.195E-03 | CA2, NR1H4, ABCG2 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 2.882E-04 | 3.650E-03 | CA2, CA4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Aortic aneurysm | I71 | MMP12; |
NA: NA | Anaplastic mixed oligoastrocytoma | NA | FLT3; |
C00-D49: Neoplasms | Cancer | C00-C96 | FLT3; HIF1A; CA1; CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | FLT3; HIF1A; CA9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | FLT3; |
C00-D49: Neoplasms | Prostate cancer | C61 | FLT3; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A; CA9; |
C00-D49: Neoplasms | Myelofibrosis | C94.4, D47.4 | FLT3; |
C00-D49: Neoplasms | Myeloid leukemia | C92 | FLT3; |
I00-I99: Diseases of the circulatory system | Pulmonary arterial hypertension | I27.0, I27.2 | HIF1A; |
C00-D49: Neoplasms | Glioblastoma | NA | FLT3; |
C00-D49: Neoplasms | Gliosarcoma | NA | FLT3; |
NA: NA | GIST | NA | FLT3; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | CA1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | MMP12; |
J00-J99: Diseases of the respiratory system | Airway inflammation | J00-J99 | FLT3; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | AML | NA | FLT3; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
A00-B99: Certain infectious and parasitic diseases | Human immunodeficiency virus infection | B20-B26 | FLT3; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4; CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | FLT3; |
NA: NA | Hematopoietic stem cell transplantation | NA | FLT3; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; CA1; |
C00-D49: Neoplasms | Colon cancer | C50 | FLT3; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | FLT3; |
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | CA1; |
C00-D49: Neoplasms | CLL | NA | FLT3; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | MMP12; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | MMP12; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Acute lymphoblastic leukemia | C91.0 | FLT3; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | FLT3; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | MMP12; |
C00-D49: Neoplasms | Breast cancer | C50 | FLT3; CA9; |
C00-D49: Neoplasms | Leukemia | C90-C95 | FLT3; |